Postinflammatory hyperpigmentation - Postinflamatorna Hiperpigmentacija
Postinflamatorna Hiperpigmentacija (Postinflammatory hyperpigmentation) je stanje kože koje karakterizira povećanje pigmenta u koži nakon upale kože. postinflamatorna hiperpigmentacija (postinflammatory hyperpigmentation) može biti uzrokovana produženim izlaganjem suncu, upalom ili drugim ozljedama kože, uključujući one povezane s aknama. Ljudi s tamnijim tonovima kože obično su skloniji hiperpigmentaciji zbog prekomjernog izlaganja suncu.
☆ U rezultatima Stiftung Warentest-a za 2022. iz Njemačke, zadovoljstvo potrošača ModelDerm-om bilo je samo nešto niže nego s plaćenim telemedicinskim konsultacijama.
References
Postinflammatory hyperpigmentation (PIH) je čest problem kože koji se javlja nakon upale ili ozljede kože. Ima tendenciju da traje dugo i pogoršava se kod ljudi sa tamnijim tonovima kože (Fitzpatrick skin types III–VI) . Iako često postaje bolje samo od sebe, to može potrajati, pa je liječenje često potrebno duže vrijeme. Kombinacija različitih tretmana najbolje djeluje.
Postinflammatory hyperpigmentation (PIH) is a common acquired cutaneous disorder occurring after skin inflammation or injury. It is chronic and is more common and severe in darker-skinned individuals (Fitzpatrick skin types III–VI). While the condition typically improves spontaneously, this process can take months to years, necessitating prolonged treatment. Combination therapy is the most effective.
Postinflammatory hyperpigmentation (PIH) is a common acquired cutaneous disorder occurring after skin inflammation or injury. It is chronic and is more common and severe in darker-skinned individuals (Fitzpatrick skin types III–VI). While the condition typically improves spontaneously, this process can take months to years, necessitating prolonged treatment. Combination therapy is the most effective.
Postinflammatory hyperpigmentation je uobičajena posljedica upale kože. Ima tendenciju da zahvati osobe tamnije puti teže i češće. Istraživanja pokazuju da su problemi poput postinflammatory hyperpigmentation jedan od glavnih razloga zašto ljudi s tamnijim tonovima kože traže dermatološku njegu. Rano liječenje je ključno za rješavanje postinflammatory hyperpigmentation i obično počinje upravljanjem početnim upalnim stanjem. Prva linija tretmana obično uključuje upotrebu lokalnih agenasa koji posvjetljuju kožu zajedno sa kremom za sunčanje za zaštitu. Ovi agensi, poput hydroquinone, azelaic acid, kojic acid, arbutin, licorice extracts , mogu efikasno smanjiti prekomjernu pigmentaciju. Osim toga, retinoids, mequinol, ascorbic acid, niacinamide, N-acetyl glucosamine, soy se također koriste kao sredstva za depigmentaciju, s novim tretmanima koji se pojavljuju. Dok su lokalni tretmani obično efikasni za površinsku hiperpigmentaciju, procedure (laser, chemical peel) mogu biti potrebne za tvrdoglave slučajeve. Važno je biti oprezan s ovim tretmanima kako biste izbjegli iritaciju i pogoršanje postinflammatory hyperpigmentation.
Postinflammatory hyperpigmentation is a common sequelae of inflammatory dermatoses that tends to affect darker skinned patients with greater frequency and severity. Epidemiological studies show that dyschromias, including postinflammatory hyperpigmentation, are among the most common reasons darker racial/ethnic groups seek the care of a dermatologist. The treatment of postinflammatory hyperpigmentation should be started early to help hasten its resolution and begins with management of the initial inflammatory condition. First-line therapy typically consists of topical depigmenting agents in addition to photoprotection including a sunscreen. Topical tyrosinase inhibitors, such as hydroquinone, azelaic acid, kojic acid, arbutin, and certain licorice extracts, can effectively lighten areas of hypermelanosis. Other depigmenting agents include retinoids, mequinol, ascorbic acid, niacinamide, N-acetyl glucosamine, and soy with a number of emerging therapies on the horizon. Topical therapy is typically effective for epidermal postinflammatory hyperpigmentation; however, certain procedures, such as chemical peeling and laser therapy, may help treat recalcitrant hyperpigmentation. It is also important to use caution with all of the above treatments to prevent irritation and worsening of postinflammatory hyperpigmentation.
Postinflammatory hyperpigmentation is a common sequelae of inflammatory dermatoses that tends to affect darker skinned patients with greater frequency and severity. Epidemiological studies show that dyschromias, including postinflammatory hyperpigmentation, are among the most common reasons darker racial/ethnic groups seek the care of a dermatologist. The treatment of postinflammatory hyperpigmentation should be started early to help hasten its resolution and begins with management of the initial inflammatory condition. First-line therapy typically consists of topical depigmenting agents in addition to photoprotection including a sunscreen. Topical tyrosinase inhibitors, such as hydroquinone, azelaic acid, kojic acid, arbutin, and certain licorice extracts, can effectively lighten areas of hypermelanosis. Other depigmenting agents include retinoids, mequinol, ascorbic acid, niacinamide, N-acetyl glucosamine, and soy with a number of emerging therapies on the horizon. Topical therapy is typically effective for epidermal postinflammatory hyperpigmentation; however, certain procedures, such as chemical peeling and laser therapy, may help treat recalcitrant hyperpigmentation. It is also important to use caution with all of the above treatments to prevent irritation and worsening of postinflammatory hyperpigmentation.
